An estimated 20 million Americans have some form of thyroid disease, but up to 60…
Read More
Each year, the American Thyroid Association® (ATA®) honors clinicians, academicians and early career researchers who…
The ATA announces with pleasure that Jacqueline Jonklaas, MD, PhD, a Professor of Endocrinology at…
Coverage from the American Thyroid Association® (ATA) 2024 Meeting October 30-November 3, 2024 Sheraton Grand…
From Clinical Thyroidology® for the Public: Treatment options for Graves’ disease include antithyroid drugs (ATDs),…
Read and share these new open access articles today: The Official Journal of: American Thyroid…
The Official Journal of: American Thyroid Association® A Conversation with Samuel Refetoff, MD: How Treating…
Shifting Paradigms in Graves’ Disease Management: An Updated Survey of Clinical Practice and Emerging Trends…
Thyroglobulin Assay Interferences-The Importance of Testing for Thyroglobulin Autoantibodies and Heterophile Antibodies Rosa Paula Mello…
From Clinical Thyroidology® for the Public: Recently, more and more physicians have been preferring treating…
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.